Jianping Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jianping Jin has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Bin Zhao
Ministry of Education Key Laboratory of Biosystems Homeostasis and Protection and Zhejiang Key Laboratory of Molecular Cancer Biology, Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University
5 shared publications - Pinglong Xu
MOE Laboratory of Biosystems Homeostasis and Protection, Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China
5 shared publications - Xin-Hua Feng
MOE Laboratory of Biosystems Homeostasis and Protection, Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China
4 shared publications Yilin Chen
Life Sciences Institute, Zhejiang University, Hangzhou, China
4 shared publicationsJianing Yan
Department of General Surgery, Sir Run Run Shaw Hospital Affiliated to School of Medicine, Zhejiang University, Hangzhou, China
3 shared publications- Li Shen
The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China
3 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
DCAF6 reprograms TGF-β responses through TRIM33 destruction
TGF-β signaling plays a pivotal role in regulating numerous cellular processes, primarily through the Smad-dependent pathway. Disruptions of the pathway are associated with developmental disorders and life-threatening diseases, such as cancer. It has been reported that TRIM33 inactivates Smad4 signaling and also drives its own signaling responses. However, the mechanism controlling TRIM33 activity has remained unclear. In this study, we identify DCAF6 as a previously unrecognized ubiquitin ligase for TRIM33. DCAF6 targets TRIM33 at Lys850 for ubiquitin-dependent proteasomal degradation, thus abolishing TRIM33-mediated mono-ubiquitination of Smad4. As such, DCAF6 induces dual consequences: it enhances Smad4-dependent transcriptional and growth inhibitory responses, while simultaneously eliminating TRIM33-dependent developmental responses. Conversely, DCAF6 knockout suppresses Smad4-dependent responses while amplifying TRIM33-dependent responses. Therefore, DCAF6 operates as a critical regulator in the balance of TGF-β signaling between the Smad4 and TRIM33 pathways. These insights deepen our understanding of the dynamics and fate control of TGF-β signaling and may open avenues for therapeutic approaches targeting TGF-β in diseases.
- 28 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Open AccessDCAF6 reprograms TGF-β responses through TRIM33 destruction
TGF-β signaling plays a pivotal role in regulating numerous cellular processes, primarily through the Smad-dependent pathway. Disruptions of the pathway are associated with developmental disorders and life-threatening diseases, such as cancer. It has been reported that TRIM33 inactivates Smad4 signaling and also drives its own signaling responses. However, the mechanism controlling TRIM33 activity has remained unclear. In this study, we identify DCAF6 as a previously unrecognized ubiquitin ligase for TRIM33. DCAF6 targets TRIM33 at Lys850 for ubiquitin-dependent proteasomal degradation, thus abolishing TRIM33-mediated mono-ubiquitination of Smad4. As such, DCAF6 induces dual consequences: it enhances Smad4-dependent transcriptional and growth inhibitory responses, while simultaneously eliminating TRIM33-dependent developmental responses. Conversely, DCAF6 knockout suppresses Smad4-dependent responses while amplifying TRIM33-dependent responses. Therefore, DCAF6 operates as a critical regulator in the balance of TGF-β signaling between the Smad4 and TRIM33 pathways. These insights deepen our understanding of the dynamics and fate control of TGF-β signaling and may open avenues for therapeutic approaches targeting TGF-β in diseases.
- Open Access
- 4 September 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 69 (05)
Regulation of R-loops by nucleic acid and protein modifications
R-loop, a three-stranded nucleic acid structure consisting of the RNA:DNA hybrid and the displaced singlestranded DNA, is crucial for many cellular processes but could be a threat to genome integrity if dysregulated. The homeostasis of R-loops is governed by various factors including helicases, nucleases, and chromatin remodelers. Since there are many excellent reviews about R-loops, we focus on discussing how R-loop homeostasis is regulated via nucleic acid and protein modifications. We summarize how RNA modifications such as N6-methyladenosine (m6A), N5-methylcytosine (m5C), and potentially 3-methylcytidine (m3C), alongside DNA modifications such as deamination, methylation, and oxidation, influence R-loop dynamics. Moreover, we discuss how protein modifications, including ubiquitination, SUMOylation, acetylation, methylation, and phosphorylation, modulate the activity, stability, or recruitment of R-loop processing factors. Importantly, these modifications often interact with each other and exhibit context-dependent roles, either promoting R-loop formation or facilitating resolution. Elucidating how these chemical codes orchestrate R-loop homeostasis will facilitate our understanding of the mechanisms governing R-loop homeostasis and could provide some insights into genome maintenance, gene expression, and pathogenesis caused by R-loop dysregulation.
- 4 September 2025
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 69 (05)
Open AccessRegulation of R-loops by nucleic acid and protein modifications
R-loop, a three-stranded nucleic acid structure consisting of the RNA:DNA hybrid and the displaced singlestranded DNA, is crucial for many cellular processes but could be a threat to genome integrity if dysregulated. The homeostasis of R-loops is governed by various factors including helicases, nucleases, and chromatin remodelers. Since there are many excellent reviews about R-loops, we focus on discussing how R-loop homeostasis is regulated via nucleic acid and protein modifications. We summarize how RNA modifications such as N6-methyladenosine (m6A), N5-methylcytosine (m5C), and potentially 3-methylcytidine (m3C), alongside DNA modifications such as deamination, methylation, and oxidation, influence R-loop dynamics. Moreover, we discuss how protein modifications, including ubiquitination, SUMOylation, acetylation, methylation, and phosphorylation, modulate the activity, stability, or recruitment of R-loop processing factors. Importantly, these modifications often interact with each other and exhibit context-dependent roles, either promoting R-loop formation or facilitating resolution. Elucidating how these chemical codes orchestrate R-loop homeostasis will facilitate our understanding of the mechanisms governing R-loop homeostasis and could provide some insights into genome maintenance, gene expression, and pathogenesis caused by R-loop dysregulation.
- Open Access
- 19 June 2025
- Published by Springer Nature in Research Square
DNA polymerase iota alleviates replication stress-induced genome instability during mitosis
DNA polymerase iota (Pol ι) is a Y-family lesion bypass polymerases, characterized by its remarkably low fidelity. While Pol ι is ubiquitously expressed in nearly all cell types, its function remains largely undefined. Previous studies in cellular and mouse models deficient in Pol ι have revealed no discernible phenotype. In this report, we show that Pol ι plays an important role in mitotic DNA synthesis. Cells lacking Pol ι exhibit heightened vulnerability to replication stress, increased formation of micronuclei, and accumulation of chromosomal breaks. The protein level of Pol ι is tightly regulated and restricted to G2/M phase cells via CRL7/FBXW11-mediated proteasomal degradation. The absence of Pol ι during S phase ensures that its error-prone DNA synthesis activity is excluded from interfering with normal DNA replication. These findings suggest that Pol ι function is critical in resolving DNA damage-induced replication stress prior to the completion of mitosis.
- 19 June 2025
- Published by Springer Nature in Research Square
Open AccessDNA polymerase iota alleviates replication stress-induced genome instability during mitosis
DNA polymerase iota (Pol ι) is a Y-family lesion bypass polymerases, characterized by its remarkably low fidelity. While Pol ι is ubiquitously expressed in nearly all cell types, its function remains largely undefined. Previous studies in cellular and mouse models deficient in Pol ι have revealed no discernible phenotype. In this report, we show that Pol ι plays an important role in mitotic DNA synthesis. Cells lacking Pol ι exhibit heightened vulnerability to replication stress, increased formation of micronuclei, and accumulation of chromosomal breaks. The protein level of Pol ι is tightly regulated and restricted to G2/M phase cells via CRL7/FBXW11-mediated proteasomal degradation. The absence of Pol ι during S phase ensures that its error-prone DNA synthesis activity is excluded from interfering with normal DNA replication. These findings suggest that Pol ι function is critical in resolving DNA damage-induced replication stress prior to the completion of mitosis.
- Open Access
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation
Roles of liver-specific genes (LSGs) in tumor initiation and progression are rarely explored in hepatocellular carcinoma (HCC). Here we show that LSGs are generally downregulated in HCC tumor tissues compared to non-HCC liver tissues, and low-LSG HCCs show poor prognosis and the activated c-Myc pathway. Among the c-Myc- and patient prognosis-associated LSGs, PGRMC1 significantly blocks c-Myc-induced orthotopic HCC formation. The role of PGRMC1 depends on its localization to the endoplasmic reticulum (ER) membrane, where PGRMC1 interacts with PERK through their ER luminal domains. This interaction in turn activates PERK in an ER stress-independent manner, which phosphorylates eIF2α and consequently inhibits c-Myc protein translation. In HCC patients, PGRMC1 level is significantly reduced in tumor tissues and negatively associated with the c-Myc signature. Patients with low-PGRMC1 in their tumors have poor prognosis. Collectively, deregulated LSGs in HCC are associated with the c-Myc pathway activation and PGRMC1 blocks c-Myc-induced hepatic carcinogenesis through promoting ER stress-independent PERK activation.
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessLiver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation
Roles of liver-specific genes (LSGs) in tumor initiation and progression are rarely explored in hepatocellular carcinoma (HCC). Here we show that LSGs are generally downregulated in HCC tumor tissues compared to non-HCC liver tissues, and low-LSG HCCs show poor prognosis and the activated c-Myc pathway. Among the c-Myc- and patient prognosis-associated LSGs, PGRMC1 significantly blocks c-Myc-induced orthotopic HCC formation. The role of PGRMC1 depends on its localization to the endoplasmic reticulum (ER) membrane, where PGRMC1 interacts with PERK through their ER luminal domains. This interaction in turn activates PERK in an ER stress-independent manner, which phosphorylates eIF2α and consequently inhibits c-Myc protein translation. In HCC patients, PGRMC1 level is significantly reduced in tumor tissues and negatively associated with the c-Myc signature. Patients with low-PGRMC1 in their tumors have poor prognosis. Collectively, deregulated LSGs in HCC are associated with the c-Myc pathway activation and PGRMC1 blocks c-Myc-induced hepatic carcinogenesis through promoting ER stress-independent PERK activation.
- Open Access
- 11 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
RNF214 is an understudied ubiquitin ligase with little knowledge of its biological functions or protein substrates. Here we show that the TEAD transcription factors in the Hippo pathway are substrates of RNF214. RNF214 induces non-proteolytic ubiquitylation at a conserved lysine residue of TEADs, enhances interactions between TEADs and YAP, and promotes transactivation of the downstream genes of the Hippo signaling. Moreover, YAP and TAZ could bind polyubiquitin chains, implying the underlying mechanisms by which RNF214 regulates the Hippo pathway. Furthermore, RNF214 is overexpressed in hepatocellular carcinoma (HCC) and inversely correlates with differentiation status and patient survival. Consistently, RNF214 promotes tumor cell proliferation, migration, and invasion, and HCC tumorigenesis in mice. Collectively, our data reveal RNF214 as a critical component in the Hippo pathway by forming a signaling axis of RNF214-TEAD-YAP and suggest that RNF214 is an oncogene of HCC and could be a potential drug target of HCC therapy.
- 11 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessThe RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
RNF214 is an understudied ubiquitin ligase with little knowledge of its biological functions or protein substrates. Here we show that the TEAD transcription factors in the Hippo pathway are substrates of RNF214. RNF214 induces non-proteolytic ubiquitylation at a conserved lysine residue of TEADs, enhances interactions between TEADs and YAP, and promotes transactivation of the downstream genes of the Hippo signaling. Moreover, YAP and TAZ could bind polyubiquitin chains, implying the underlying mechanisms by which RNF214 regulates the Hippo pathway. Furthermore, RNF214 is overexpressed in hepatocellular carcinoma (HCC) and inversely correlates with differentiation status and patient survival. Consistently, RNF214 promotes tumor cell proliferation, migration, and invasion, and HCC tumorigenesis in mice. Collectively, our data reveal RNF214 as a critical component in the Hippo pathway by forming a signaling axis of RNF214-TEAD-YAP and suggest that RNF214 is an oncogene of HCC and could be a potential drug target of HCC therapy.
- Open Access
- 5 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107264
Applications of protein ubiquitylation and deubiquitylation in drug discovery
- 5 April 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107264
Open AccessApplications of protein ubiquitylation and deubiquitylation in drug discovery
- Open Access
- 18 May 2023
- Published by Springer Nature in Research Square
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
RNF214 is an understudied ubiquitin ligase without any knowledge of its biological functions or specific protein substrates. Using an APEX2-mediated proximity labeling method coupled with the mass spectrometry technique, we identified the TEAD transcription factors in the Hippo pathway as interactors of RNF214. We showed that RNF214 induces non-proteolytic ubiquitylation at a conserved single lysine residue of TEADs, enhances the interactions between TEADs and the transcription coactivators of the Hippo pathway including YAP and TAZ, and then promotes transactivation of the downstream genes of the Hippo signaling. Moreover, we proved that YAP and TAZ could bind polyubiquitin chains, implying the underlying mechanisms by which RNF214 regulates the Hippo pathway. Furthermore, we found that RNF214 is overexpressed in hepatocellular carcinoma (HCC). Clinical and statistical analysis indicated that high expression levels of RNF214 are associated with low differentiation status and poor prognosis of HCC. Consistently, we showcased that RNF214 promotes proliferation, migration and invasion of HCC cells and HCC tumorigenesis in mouse models via the Hippo pathway. Collectively, our data revealed that RNF214 is a critical component in the Hippo pathway by forming a new signaling axis of RNF214-TEAD-YAP, thereby upregulating the transcriptional activities of the YAP/TAZ-TEAD complex. More importantly, our results suggest that RNF214 serves as an oncogene of HCC and could be a potential drug target of HCC therapy.
- 18 May 2023
- Published by Springer Nature in Research Square
Open AccessThe RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
RNF214 is an understudied ubiquitin ligase without any knowledge of its biological functions or specific protein substrates. Using an APEX2-mediated proximity labeling method coupled with the mass spectrometry technique, we identified the TEAD transcription factors in the Hippo pathway as interactors of RNF214. We showed that RNF214 induces non-proteolytic ubiquitylation at a conserved single lysine residue of TEADs, enhances the interactions between TEADs and the transcription coactivators of the Hippo pathway including YAP and TAZ, and then promotes transactivation of the downstream genes of the Hippo signaling. Moreover, we proved that YAP and TAZ could bind polyubiquitin chains, implying the underlying mechanisms by which RNF214 regulates the Hippo pathway. Furthermore, we found that RNF214 is overexpressed in hepatocellular carcinoma (HCC). Clinical and statistical analysis indicated that high expression levels of RNF214 are associated with low differentiation status and poor prognosis of HCC. Consistently, we showcased that RNF214 promotes proliferation, migration and invasion of HCC cells and HCC tumorigenesis in mouse models via the Hippo pathway. Collectively, our data revealed that RNF214 is a critical component in the Hippo pathway by forming a new signaling axis of RNF214-TEAD-YAP, thereby upregulating the transcriptional activities of the YAP/TAZ-TEAD complex. More importantly, our results suggest that RNF214 serves as an oncogene of HCC and could be a potential drug target of HCC therapy.
- Open Access
- 28 August 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (10) , 102431
Nontraditional translation is the key to UFMylation and beyond
- 28 August 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (10) , 102431
Open AccessNontraditional translation is the key to UFMylation and beyond
- Open Access
- 8 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (41)
HSPA13 facilitates NF-κB–mediated transcription and attenuates cell death responses in TNFα signaling
HSPA13 is a novel checkpoint regulator in the TNFα signaling pathway controlling cellular physiological outcomes.
- 8 October 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (41)
Open AccessHSPA13 facilitates NF-κB–mediated transcription and attenuates cell death responses in TNFα signaling
HSPA13 is a novel checkpoint regulator in the TNFα signaling pathway controlling cellular physiological outcomes.